Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 97,733 | 89,897 | 112,289 | 37,521 |
| Depreciation Amortization | 0 | 10,682 | 6,999 | 3,445 | 13,846 |
| Income taxes - deferred | 0 | 66,374 | 54,960 | 75,573 | 21,932 |
| Other Working Capital | N/A | -110,057 | 26,716 | -200,647 | -84,815 |
| Other Operating Activity | 0 | 3,414 | 2,503 | 1,383 | 2,949 |
| Operating Cash Flow | $0 | $68,146 | $181,075 | $-7,957 | $-8,567 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -10,460 | -4,666 | -2,308 | -953 |
| Other Investing Activity | 0 | -150 | -150 | -52 | -332 |
| Investing Cash Flow | $0 | $-10,610 | $-4,816 | $-2,360 | $-1,285 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -3,000 | -3,000 | N/A | -6,954 |
| Other Financing Activity | 0 | 61 | 61 | 61 | -356 |
| Financing Cash Flow | $0 | $-2,939 | $-2,939 | $61 | $-7,310 |
| Beginning Cash Position | 0 | 427,284 | 427,284 | 427,284 | 444,446 |
| End Cash Position | 0 | 481,881 | 600,604 | 417,028 | 427,284 |
| Net Cash Flow | $0 | $54,597 | $173,320 | $-10,256 | $-17,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 68,146 | 181,075 | -7,957 | -8,567 |
| Capital Expenditure | 0 | -10,460 | -4,666 | -2,308 | -953 |
| Free Cash Flow | 0 | 57,686 | 176,409 | -10,265 | -9,520 |